This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. 
UK Biobank
Intake of alcoholic drinks at baseline was obtained from a touchscreen questionnaire which was used to extract information on status, intake frequency (per month) and beverage type (ie, red wine, white wine/champagne, beer, spirits, fortified wine). See https://biobank.ctsu.ox.ac.uk/crystal/docs/TouchscreenQuestionsMainFinal.pdf. Information on total alcohol amount was then calculated and converted to a standard scale of grams/week (1 unit=8 grams of alcohol). , 436 (ICD-9) or earlier ICD equivalents, or strokes not specified as ischemic or haemorrhagic in study specific codes.
Corresponding ICD-6, 7 or 8 codes are used for ERFC studies that recorded outcomes using earlier ICD versions.
Annex 4. Statistical methods used for estimating years of life lost
We used three pieces of information to estimate reductions in life expectancy associated with alcohol consumption at baseline (henceforth "exposure groups" pre-defined as alcohol consumption >0-≤100, >100-≤200, >200-≤350 and >350 grams/week):
(i) age-at-risk specific hazard ratios for all-cause (and cause-specific) mortality in each exposure group versus the reference (derived from the ERFC and UK Biobank);
(ii) population all-cause (and cause-specific) mortality rates (derived from the detailed mortality component of the CDC WONDER database of the US Centers for Disease Control and Prevention); and (iii) prevalence of exposure groups in the population (derived from the ERFC and UK Biobank).
We estimated population survival curves for each exposure group, utilising estimated age-at-risk specific hazard ratios for mortality by exposure groups in the ERFC, and UK Biobank and routine statistics on overall population mortality rates. We estimated reductions in life-expectancy as differences in areas under any two survival curves compared. To calculate an appropriate mortality rate for the reference group (i.e. defined as those drinking >0-≤100 grams/week), we used ERFC and UK Biobank data on exposure prevalence estimates, as described below.
Age-at-risk specific hazard ratios for mortality by exposure groups were estimated from ERFC and UK Biobank data separately for each sex. Specifically, a Cox regression model stratified by cohort and trial arm (where applicable) was fitted separately for each sex using a dataset in which participant ages-at-risk were deterministically updated by splitting the follow up times every 5-years and recalculating an age-at-risk variable at the beginning of each 5-year interval of follow up. Interactions between baseline exposure groups and linear and quadratic terms for the age-at-risk variable were included in the model to obtain smoothed hazard ratios. Thus, for participant in stratum with exposure group indicator variable ( ) (i.e. dummy variable equal to 1 if in exposure group is and zero otherwise) the log hazard rate at time since baseline was modelled as: log(ℎ ( )) = log(ℎ 0 ( )) + ∑ from which the age-at-risk specific hazard ratios (and 95% CIs) for mortality were obtained as linear combinations of the relevant estimated coefficients, with age-at-risk fixed at values corresponding to midpoints of 5-year age-groups from age 40 onwards.
Population all-cause (and cause-specific) mortality rates per 100,000 were obtained in 5-year age-groups for the US population during years 2007-2010 from the Center for Disease Control (CDC) WONDER online database (https://wonder.cdc.gov/ucd-icd10.html), as well as for 15 EU countries during year 2000
(http://ec.europa.eu/eurostat/data/database). Because the mortality rates were provided only up to age-group 80-84 years, but we desired to estimate the overall population survival curves, we used a Poisson regression model with linear and quadratic terms for the midpoints of 5-year age-groups to smooth and extrapolate the mortality rates. Next, assuming exponential survival (i.e. constant hazard) within each 5-year age group, we estimated the age-specific survival probability as = (−5 × ) and derived the overall population survival curves from age 35 onwards as the product of the relevant age-group specific survival probabilities.
In order to infer population mortality rates appropriate for the reference exposure group used in our estimation of agespecific hazard ratios (i.e. defined as those drinking >0-≤100 grams/week), we used logistic regression to model the agespecific prevalence of the alchol consumption categories in ERFC and UK Biobank cohorts by sex and decade of recruitment. We used the age-specific prevalence estimates for the decade commencing in the year 1990 to infer the agespecific mortality rates appropriate for our reference group 0 as:
Where is the population mortality rate for age group , is the age-specific prevalence of exposure group , and is the age-specific hazard ratio in comparison of exposure group versus reference group ( = 0). The age-specific mortality rates in each of the non-reference exposure groups were then inferred in turn by multiplying the age-specific mortality rate for the reference group 0 by the age-specific hazard ratios based on ERFC and UK Biobank data and equation (2) above used to infer the exposure group-specific population survival curves. Finally, reductions in life expectancy according to baseline exposure groups were estimated as difference in the areas under the survival curves for the reference group and each of the non-reference exposure groups in turn. The areas under curves were calculated by numerical integration.
Monte Carlo simulation was used to calculate confidence intervals for the estimated reductions in life expectancy, taking into account uncertainty in the age-at-risk specific hazard ratios calculated from equation (1) above. In particular, new parameter estimates were randomly drawn from the multivariate normal distribution defined by the fitted model mean and covariance matrix, 200 times, and the above procedure repeated for each draw to calculate reductions in lifeexpectancy for each index age of interest. Assuming asymptotic normality, the standard deviation of the 200 Monte Carlo estimates of reductions in life expectancy for each index age were used to calculate 95% confidence intervals around the originally estimated value. Histograms were inspected to judge that normality assumption was reasonable. eTable 5. Hazard ratios for cardiovascular outcomes amongst current drinkers, without and with adjustment for usual or baseline levels of potential confounders, mediators and proxies thereof. eTable 6. Hazard ratios for death from lung cancer and digestive related cancer outcomes per 100 grams/wk higher usual alcohol consumption amongst current drinkers, without and with adjustment for usual or baseline levels of potential confounders, mediators and proxies thereof.
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eTable 7: Sex-specific hazard ratios for major cardiovascular outcomes per 100 grams/week increase in usual alcohol consumption amongst current drinkers.
eTable 8: Sensitivity analyses: Hazard ratios for major cardiovascular outcomes per 100 grams/week increase in usual alcohol consumption amongst current drinkers. eFigure 9a: Hazard ratios per 100 grams/week higher usual alcohol consumption for subtypes of cardiovascular outcomes amongst current drinkers, adjusted for body mass index.
eFigure 9b. Shape of association of usual alcohol consumption with all-cause mortality and all cardiovascular disease amongst current drinkers, adjusted for body mass index.
eFigure 10: Shape of association between baseline alcohol consumption, including ex-and non-drinkers, with all-cause mortality and cardiovascular disease.
eFigure 11: Hazard ratios per 100 grams/week higher baseline alcohol consumption for subtypes of cardiovascular outcomes amongst current drinkers with recorded baseline alcohol consumption (left) compared against all current drinkers using multiple imputation (right).
eFigure 12: Shapes of associations of baseline alcohol consumption with stroke and coronary outcomes amongst alcohol drinkers.
eFigure 13: Best fitting 2 nd degree fractional polynomial for the modelled shape of association between baseline alcohol consumption with all-cause mortality. eFigure 14: Hazard ratios per 100 grams/week higher usual alcohol consumption for subtypes of cardiovascular outcomes amongst current drinkers from a fixed-effect meta-analysis. eFigure 15: Hazard ratios per 100 grams/week higher usual alcohol consumption for subtypes of cardiovascular outcomes amongst current drinkers, from fixed-effect analysis with inclusion of studies with fewer than 5 outcomes of a particular type.
eFigure 16: Shape of association between usual alcohol consumption with major vascular restricted to ERFC studies recording both coronary death and non-fatal MI endpoints. eFigure 18: Hazard ratios per 100 grams/week higher alcohol consumption for all-cause mortality and different cardiovascular outcomes amongst current drinkers and by alcohol type. eFigure 19a-e: Hazard ratios per 100 gram/week increase in usual alcohol consumption for major vascular outcomes and all cause mortality amongst current drinkers by study/cohort-level characteristics. eFigure 20a-e: Hazard ratios per 100 gram/week increase in usual alcohol consumption for major cardiovascular outcomes amongst current drinkers by individual-level characteristics. eFigure 21. Funnel plots and assessment of small-study effects for study-specifc hazard ratios per 100 gram/week increase in usual alcohol consumption for major vascular outcomes amongst current drinkers. eFigure 22. Estimated future years of life lost in individuals reporting drinking above a range of hypothetical alcohol consumption thresholds compared to those reporting drinking less than the hypothetical alcohol consumption thresholds. Continued over page eTable 1: Alcohol consumption ascertainment methods for 83 studies in the ERFC, EPIC-CVD and UK Biobank.
Study
1 Calculated: alcohol amount is the product of the reported frequency (eg, more than once per day, more than once per month) and the individual reported intake per occasion (eg, 2 glasses on each occasion). Reported: alcohol amount is provided within a specified time period (eg, number of glasses in the past week) FFQ=food frequency questionnaire. eTable 2: Summary of individual-level baseline characteristics, mortality and major cardiovascular outcomes by baseline alcohol consumption categories.
*All-cause mortality events derived only from the 13,670 participants in the random sub-cohort of EPIC-CVD, rather than from the much larger number of participants in the full prospective EPIC study eTable 3: Summary of events for 83 studies, restricted to current drinkers.
Cohort abbreviation
Total participants All-cause mortality -CVD  26036  784  12758  5507  581  4926  3293  686  353  1146  5919  4963  896  2045  1675  370  -----Nested case-control studies  FLETCHER  572  -85  ----------85  -------GLOSTRUP  313  14  63  -------61  47  14  2  2  ------HPFS  575  69  181  6  6  -2  2  -1  140  130  10  14  -14  ---18  2  WHIHABPS  108  108  84  71  2  69  71  ---9  9  -3  -3  -----SUBTOTAL  1568  191  413  77  8  69  73  2  -1  210  186  24  104  2  17  ---18  2  Clinical trials  AFTCAPS  2566  46  117  14  -14  5  --9  51  50  1  38  38  -7  --5  -MRFIT  3453  239  218  18  4  14  1  -1  15  170  142  28  12  -12  4  5  1  -2  PROSPER  1710  104  181  45  2  43  ---45  82  82  -16  -16  33  ----WOSCOPS  5070  149  293  50  -50  ---50  188  188  -47  -47  -----SUBTOTAL  12799  538  809  127  6  121  6  -1  119  491  462  29  113  38  75  44  5  1  5  2  Prospective cohort studies  UKBIOBANK  326372  6720  7469  1616  108  1508  997  214  202  181  1953  1787  166  3404  3126  278  255  4  34  -65  326372  6720  7469  1616  108  1508  997  214  202  181  1953  1787  166  3404  3126  278  255  4 HCS  2328  214  47  5  5  --1  1  3  10  -10  11  -11  2  -2  -9  HIMS  5250  2017  938  288  32  256  140  47  3  88  308  235  73  169  132  37  133  6  9  -10  HISAYAMA  864  190  123  75  3  72  50  18  6  -25  23  2  1  -1  -1  1  -3  HONOL  883  185  91  43  15  28  2  16  1  23  34  29  5  6  -6  -2  1  -3  HUBRO  11498  539  124  42  42  -6  9  2  13  28  -28  8  -8  7  6  6  -11  IKNS  2701  358  188  131  12  119  69  24  5  33  30  14  16  4  -4  18  1  --2  KARELIA  41  31  28  5  1  4  1  --4  13  10  3  2  -2  8  ----KIHD  1805  512  535  126  14  112  86  33  2  3  319  315  4  72  69  3  2  -2  -5  LASA  1458  396  60  10  -10  ---10  26  26  ----24  ----MATISS83  2004  364  251  71  6  65  20  7  1  40  60  38  22  8  2  6  38  54  7  --MATISS87  1401  182  122  37  -37  7  3  1  26  30  14  16  2  -2  18  27  3  1  -MATISS93  648  18  25  5  -5  1  1  1  2  11  9  2  1  1  -3  4  1  --MCVDRFP  14655  1106  274  56  56  -4  20  12  18  92  -92  26  -26  15  11  3  6  14  MESA  2388  161  85  39  -39  33  5  -1  30  30  -13  -13  -----MICOL  15563  382  116  23  23  -4  2  -15  53  -53  32  -32  ----1  MONICA_KORA1  757  124  85  5  5  --2  -2  55  38  17  4  -4  9  --1  2  MONICA_KORA2  2655  177  83  3  3  ---1  2  63  41  22  7  -7  6  -1  1  -MONICA_KORA3  3022  378  177  30  30  -8  8  -13  104  81  23  21  -21  4  2  -7  -MRCOLD  4689  2736  1111  340  340  -22  27  4  200  221  -221  281  -281  67  29  14  -37  NFR  2768  287  103  24  24  -2  7  1  10  49  -49  25  -25  ----3  NHANESI  6828  1482  915  191  62  129  54  24  9  98  301  162  139  228  121  107  79  22  22  -11  NHANESIII  3677  753  225  51  51  ----51  33  -33  64  -64  8  -11  -3  NPHSII  2314  325  197  53  7  46  29  5  5  14  124  113  11  1  -1  --3  10  5  NSHS  708  46  46  13  1  12  -1  -12  3  -3  30  30  ------OPPHED  5793  225  53  16  16  -2  5  -9  21  -21  4  -4  2  5  1  --OSAKA  7521  290  108  61  8  53  21  14  4  22  20  16  4  1  -1  21  1  1  1  2  OSLO2  3824  701  164  45  45  -6  16  3  16  42  -42  18  -18  13  9  6  -8  PRHHP  1439  188  80  10  7  3  5  4  --39  29  10  13  7  6  --6  7  3  PRIME  7946  141  126  25  -25  18  5  -2  84  78  6  4  -4  ---12  -PROCAM  10089  423  311  37  13  24  27  6  -4  180  162  18  30  4  26  4  1  -37  5  QUEBEC  2113  543  414  89  4  85  ---89  253  229  24  14  -14  6  --46  -RANCHO  1353  558  354  132  7  125  -1  -125  149  148  1  ---7  8  11  -5  RS_I  3145  820  440  144  70  74  20  14  2  102  141  120  21  ---38  --35  12  RS_II  1119  117  80  17  7  10  2  2  -13  45  45  ----3  --9  1  RS_III  2258  28  6  1  1  --------1  -1  ---1  1  SHHEC  7919  417  410  88  5  83  21  11  12  41  208  168  40  100  86  14  1  1  1  2  4  SHIP  1746  3  48  23  -23  ---23  25  25  ---------TOYAMA  2480  68  57  30  -30  12  13  5  -21  21  ----3  ----TROMS  1134  26  9  -------5  -5  1  -1  -1  1  -1  TROMSØ  10024  862  592  244  9  235  178  29  23  11  301  272  29  12  -12  3  2  4  10  6  ULSAM  703  326  258  79  6  73  56  11  3  7  73  64  9  27  12  15  64  -3  -4  WCWC  2310  222  12  -------12  12  ---------WHITEI  3099  1606  599  181  181  -19  11  3  96  104  -104  140  -140  36  19  6  -51  WHITEII  8776  426  370  7  7  -1  1  1  4  323  297  26  24  -24  --1  -3  ZUTE  281  142  98  36  -36  ---36  41  40  1  2  -2  8  1  -1  7  SUBTOTAL  559509  38804  25038  6387  1583  4804  2917  835  357  1997  7925  6098  1827  5777  4297  1480  2704  299  218  269  341  TOTAL  599912  40317  39018  12098  2178  9920  6289  1523  711  3263  14545  11709  2776  8039  6012  1942  2748  304  219  292 Analyses restricted to individuals with basic adjustment variables plus the additional variable. Studies with fewer than five events were excluded from the analysis of each outcome. *Basic adjustment includes age, smoking and history of diabetes, and stratified by sex and EPIC centre. 1 Adjustment includes separate variables for pork, beef and lamb consumption.
2 Adjustment includes systolic blood pressure, anti-hypertinsive drug use and their interaction. eTable 6. Hazard ratios for death from lung cancer and digestive related cancer outcomes per 100 grams/wk higher usual alcohol consumption amongst current drinkers, without and with adjustment for usual or baseline levels of potential confounders, mediators and proxies thereof.
Level of adjustment

Deaths from lung cancer
Death from digestive related cancer Analyses restricted to individuals with basic adjustment variables plus the additional variable. Studies with fewer than five events were excluded from the analysis of each outcome. *Basic adjustment includes age, smoking status and history of diabetes, and stratified by sex and EPIC centre. Digestive cancers were defined as tumours of the liver, colorectum, stomach, pancreas and oesophagus.
Studies with fewer than five events were excluded from the analysis of each outcome. *Adjusted for age, smoking and history of diabetes, and stratified by sex and EPIC centre. eTable 8: Sensitivity analyses: Hazard ratios for major cardiovascular outcomes per 100 grams/week increase in usual alcohol consumption amongst current drinkers.
Studies with fewer than five events were excluded from the analysis of each outcome. *Adjusted for age, smoking and history of diabetes, and stratified by sex and EPIC centre. MI: Myocardial infarction. Response means are adjusted to age 50 years. Red squares represent associatons for females; blue squares represent associatons for males. Vertical lines represent 95% CIs.
eFigure 4: Shape of association of baseline alcohol consumption with all-cause mortality and all cardiovascular disease amongst current drinkers.
Adjusted for age, smoking and history of diabetes, and stratified by sex and EPIC centre. Studies with fewer than five events of any outcome were excluded from the analysis of that outcome. The sizes of the boxes are proportional to the inverse of the variance of the log-transformed hazard ratios. The reference category is the lowest alcohol consumption category (baseline consumption >0 and ≤25g/week). HRs are plotted against the mean baseline alcohol consumption in each category. Vertical lines represent 95% CIs. The best-fitting fractional polynomial Cox models on the log scale were: all-cause mortality, non-linear (ie, powers 0·5 and 1); and cardiovascular disease, non-linear (ie, powers 0 and 0). eFigure 5. Shape of association of usual alcohol consumption with all-cause mortality for females and males.
Adjusted for age, smoking and history of diabetes, and stratified by sex and EPIC centre. The reference category is the lowest alcohol consumption category (baseline consumption >0 and ≤25g/week). HRs are plotted against the mean usual alcohol consumption in each category. The sizes of the boxes are proportional to the inverse of the variance of the log-transformed hazard ratios. Vertical lines represent 95% CIs.
eFigure 7. Shapes of associations of usual alcohol consumption with fatal and non-fatal major cardiovascular causes.
Adjusted for age, smoking and history of diabetes, and stratified by sex and EPIC centre. Alcohol consumption categories amongst current drinkers were >0-≤50 grams/week, >50-≤100 grams/week, >100-≤150 grams/week, >150-≤250 grams/week, >250-≤350 grams/week and >350 grams/week. The reference category is the lowest baseline alcohol consumption category (>0 and ≤50g/week). HRs are plotted against the mean usual alcohol consumption in each category. Studies with fewer than five events of any outcome were excluded from the analysis of that outcome. The sizes of the boxes are proportional to the inverse of the variance of the log-transformed hazard ratios. Vertical lines represent 95% CIs.
eFigure 8. Shapes of associations of usual alcohol consumption with type of stroke.
Adjusted for age, smoking and history of diabetes, and stratified by sex and EPIC centre. Baseline alcohol consumption categories amongst current drinkers were >0-≤50 grams/week, >50-≤100 grams/week, >100-≤150 grams/week, >150-≤250 grams/week, >250-≤350 grams/week and >350 grams/week. The reference category is the lowest baseline alcohol consumption category (>0 and ≤50g/week). HRs are plotted against the mean usual alcohol consumption in each category. Studies with fewer than five events of any outcome were excluded from the analysis of that outcome. The sizes of the boxes are proportional to the inverse of the variance of the log-transformed hazard ratios. Vertical lines represent 95% CIs.
eFigure 9a: Hazard ratios per 100 grams/week higher usual alcohol consumption for subtypes of cardiovascular outcomes amongst current drinkers, additionally adjusted for body-mass index.
eFigure 9b. Shape of association of usual alcohol consumption with all-cause mortality and all cardiovascular disease amongst current drinkers, additionally adjusted for body-mass index.
Adjusted for BMI, age, smoking and history of diabetes, and stratified by sex and EPIC centre. Alcohol consumption categories amongst current drinkers were >0-≤50 grams/week, >50-≤100 grams/week, >100-≤150 grams/week, >150-≤250 grams/week, >250-≤350 grams/week and >350 grams/week. The reference category is the lowest baseline alcohol consumption category (>0 and ≤50g/week). HRs are plotted against the mean usual alcohol consumption in each category. Studies with fewer than five events of any outcome were excluded from the analysis of that outcome. The sizes of the boxes are proportional to the inverse of the variance of the log-transformed hazard ratios. Vertical lines represent 95% CIs.
eFigure 12: Shapes of associations of baseline alcohol consumption with stroke and coronary outcomes amongst alcohol drinkers Adjusted for age, smoking and history of diabetes, and stratified by sex and EPIC centre. The reference category is the lowest baseline alcohol consumption category (>0 and ≤25g/week). HRs are plotted against the mean baseline alcohol consumption in each category. Studies with fewer than five events of any outcome were excluded from the analysis of that outcome. The sizes of the boxes are proportional to the inverse of the variance of the log-transformed hazard ratios. Vertical lines represent 95% CIs. The best-fitting fractional polynomial Cox models on the log scale were: all stroke, linear (ie, powers 1); myocardial infarction, log-linear (powers 0); coronary disease excluding myocardial infarction, linear (ie, powers 1); heart failure, linear (ie, powers 1); and deaths from other types of cardiovascular disease, linear (ie, powers 1).
eFigure 13: Best fitting second degree fractional polynomial for the modelled shape of association between baseline alcohol consumption with all-cause mortality.
To estimate the alcohol consumption level at which mortality risk was lowest, we conducted nonlinear modelling by fitting a Cox regression model stratified by cohort, sex and trial arm (where applicable), to determine a best fitting second degree fractional polynomial model (FP2) for baseline alcohol consumption.
eFigure 17: Shapes of associations of baseline alcohol consumption with all-cause mortality by (a) consumption frequency, (b) consumption type* and (c) binge drinking status.
Adjusted for age, smoking and history of diabetes, and stratified by sex and EPIC centre.
*Analysis was performed separately for each alcohol consumption type (351,342 wine drinkers; 227,469 beer drinkers; 171,770 spirits drinkers). Individuals drinking more than one type of alcohol were included in each separate analysis.
eFigure 21. Funnel plots and assessment of small-study effects for study-specfic hazard ratios per 100 gram/week increase in usual alcohol consumption for major vascular outcomes amongst current drinkers.
eFigure 22. Estimated future years of life lost in individuals reporting drinking above a range of hypothetical alcohol consumption thresholds compared to those reporting drinking less than the hypothetical alcohol consumption thresholds.
Interpretation: Males who reported drinking above 196 g/wk threshold have approximately 2.7 years (95% CI: 2.4-3.1) lower life expectancy at age 40 years than those who reported drinking below 196 g/wk. Similarly, males who reported drinking above 112 g/wk threshold have approximately 1.6 years (95% CI: 1.3-1.8) lower life expectancy at 40 years than those who reported drinking below 112 g/wk.
The estimates of cumulative survival from 40 years of age onward among the drinking groups were calculated by applying hazard ratios (specific to age at risk) for all-cause mortality associated with baseline alcohol consumption to US death rates at the age of 40 years or older.
